Alliance receives virtually no analyst coverage. Two analysts have a Buy rating with a median price target of $29.00. At a recent price near $21.00 a share, the implied upside is 38.1%.
For the fourth quarter, Alliance is expected to post sales of $688.27 million, which would be up 9.5% sequentially and by 45.3% year over year. Adjusted EPS are forecast at $1.42, up 13.6% sequentially and 255% higher year over year. Full-year EPS are forecast at $4.31, an increase of more than 217%, and revenue for the year is estimated to rise by about 52.5% to $2.39 billion.
Alliance common units trade at a sales-to-enterprise value multiple of 1.2 for 2022 and 1.0 for both 2023 and 2024. The stock’s 52-week trading range is $12.60 to $27.63. Alliance pays an annual dividend of $2.00 (yield of 9.5%). Total shareholder return for the past 12 months was 62.6%.
GE Healthcare
GE Healthcare Technologies Inc. (NASDAQ: GEHC) began trading on January 3 and joined the S&P 500 index on the same day. Since the spin-off from GE, shares have added nearly 18%. GE stock is down by about 3.6% over the same period.
The new health care technology company released preliminary results on January 10, announcing fourth-quarter revenue of around $4.9 billion and full-year revenue of about $18.3 billion. Adjusted EBIT margin is expected to come in at 15% to 15.5%, up a full percentage point above the company’s earlier estimate. Free cash flow is expected to come in near the low end of the estimated range of $1.8 to $2.0 billion.
Only two analysts cover the stock until the quiet period ends early next month. At a share price of around $68.70, the stock trades above the median (and high) price target of $67.00.
Fourth-quarter estimates track the company’s own preliminary numbers, and forward estimates will not be meaningful until more analysts jump on the bandwagon.
The stock’s post-IPO range is $53.00 to $70.63. GE Healthcare does not pay a dividend, and that is something shareholders might expect to hear more about on Monday morning.
Li-Cycle
Lithium-ion battery recycler Li-Cycle Holdings Corp. (NYSE: LICY) has seen its share price decline by about 26% over the past year. Since posting a high above $15 in November 2021, the shares have dropped by more than 60%.
Lithium carbonate prices have dipped by about 20% since a high posted in November, due primarily to increased production (up 89% year over year) in China. Australian production is expected to rise by nearly a third year over year in 2023. Li-Cycle has begun operations at an Alabama plant and a facility in Rochester, New York, is under construction that is said to be capable of supplying enough batter-grade lithium to power 225,000 electric vehicles.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
